(57 days)
No
The document describes a respiratory motion correction technique based on non-rigid image registration, which is a traditional image processing method, and does not mention AI, ML, or related terms.
No.
The device is described as software that corrects respiratory motion in PET images to improve measurement accuracy; it does not claim to treat or diagnose a disease or condition.
No
HYPER Focus is a software-only device that corrects respiratory motion in PET images to improve measurement accuracy of SUV and lesion volume. It is intended to improve images, not to provide a diagnosis on its own.
Yes
The device description explicitly states "HYPER Focus is a software-only device." and describes it as an additional function implemented on previously cleared PET/CT devices.
Based on the provided information, this device is NOT an IVD (In Vitro Diagnostic).
Here's why:
- IVDs are used to examine specimens derived from the human body. The intended use and device description clearly state that HYPER Focus is a software that processes PET images obtained from previously cleared PET/CT devices. It works with imaging data, not biological samples.
- The purpose of IVDs is to provide information for diagnosis, monitoring, or treatment. While HYPER Focus aims to improve the accuracy of measurements (SUV and lesion volume) in PET images, its primary function is image processing to correct for motion artifacts. It doesn't directly analyze biological markers or provide diagnostic information from a specimen.
- The input is PET images, not biological samples. This is a key differentiator between imaging software and IVDs.
In summary, HYPER Focus is a medical image processing software designed to improve the quality and accuracy of PET images by correcting for respiratory motion. It operates on imaging data, not biological specimens, which is the defining characteristic of an IVD.
N/A
Intended Use / Indications for Use
HYPER Focus can be used to correct respiratory motion in PET images. Relative to non - corrected images, HYPER Focus can reduce respiratory motion effects and thus improve the measurement accuracy of SUV and lesion volume.
Product codes
KPS
Device Description
HYPER Focus is a software-only device. It is intended to be implemented on previously cleared PET/CT devices uMI 550 (K193241) and uMI 780 (K172143). HYPER Focus serves as an additional function for uMI 550 and uMI 780 to carry the respiratory correction. It uses the similar respiratory motion correction technique, non-rigid image registration, as the predicate device.
Mentions image processing
MotionVUE2 (Q.freeze) is a PET/CT, no-invasive image analysis software application designed to support the viewing and manipulation of medical images from PET and CT imaging modalities.
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
PET images
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Engineering bench testing was performed to support substantial equivalence and product performance claims. The evaluation and analysis used the identical raw datasets obtained from UIH's uMI 780 (K172143) and uMI 550 (K193241), and then respectively performed image reconstruction with/without HYPER Focus.
Bench test shows that HYPER Focus can reduce respiratory motion effects and improve the accuracy of SUV and sphere volume in comparison with no motion correction.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1200 Emission computed tomography system.
(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services seal on the left and the FDA acronym along with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym "FDA" in a square and the words "U.S. FOOD & DRUG ADMINISTRATION" next to it.
Shanghai United Imaging Healthcare Co.,Ltd. % Xin Gao Regulatory Affairs Manager No. 2258 Chengbei Rd., Jiading Industrial District Shanghai, Shanghai 201807 CHINA
Re: K210418
Trade/Device Name: HYPER Focus Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system Regulatory Class: Class II Product Code: KPS Dated: February 7, 2021 Received: February 11, 2021
Dear Xin Gao:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for
April 9, 2021
1
devices or postmarketing safety reporting (21 CFR 4. Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Michael D. O'Hara
For
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K210418
Device Name HYPER Focus
Indications for Use (Describe)
HYPER Focus can be used to correct respiratory motion in PET images. Relative to non - corrected images, HYPER Focus can reduce respiratory motion effects and thus improve the measurement accuracy of SUV and lesion volume.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/1 description: The image contains the logo for United Imaging. The text "UNITED" is stacked on top of the text "IMAGING". To the right of the text is a stylized letter "U" that is split in the middle by a vertical line. The logo is in a dark teal color.
510 (k) SUMMARY
1. Date of Preparation
February 7, 2021
2. Sponsor Identification
Shanghai United Imaging Healthcare Co.,Ltd. No.2258 Chengbei Rd. Jiading District, 201807, Shanghai, China
Contact Person: Xin GAO Position: Regulatory Affairs Manager Tel: +86-021-67076888-5386 Fax: +86-021-67076889 Email: xin.gao@united-imaging.com
3. Identification of Proposed Device
Trade Name: HYPER Focus Common Name: Emission Computed Tomography System Model(s): HYPER Focus
Regulatory Information Regulation Number: 21 CFR 892.1200 Regulation Name: Emission Computed Tomography System Regulatory Class: II Product Code: KPS Review Panel: Radiology
4. Identification of Predicate Device(s)
Predicate Device 510(k) Number: K113408 Device Name: Emission Computed Tomography System Model(s): GE Q.Freeze software
Regulatory Information Regulation Number: 21 CFR 892.1200 Regulation Name: Emission Computed Tomography System Regulatory Class: II Product Code: KPS Review Panel: Radiology
5. Device Description:
HYPER Focus is a software-only device. It is intended to be implemented on previously cleared PET/CT devices uMI 550 (K193241) and uMI 780 (K172143). HYPER Focus serves as an additional function for uMI 550 and uMI 780 to carry
4
Image /page/4/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" in bold, sans-serif font, stacked on top of each other. To the right of the text is a stylized "U" shape, also in a bold font. The logo is simple and modern in design.
the respiratory correction. It uses the similar respiratory motion correction technique, non-rigid image registration, as the predicate device.
Indications for Use 6.
HYPER Focus can be used to correct respiratory motion in PET images. Relative to non-corrected images, HYPER Focus can reduce respiratory motion effects and thus improve the measurement accuracy of SUV and lesion volume.
7. Comparison of Technological Characteristics with the Predicate Devices
A comparison between the technological characteristics of proposed and predicate devices is provided as below.
5
Image /page/5/Picture/1 description: The image shows the logo for United Imaging. The words "UNITED IMAGING" are stacked on top of each other in a bold, sans-serif font. To the right of the words is a stylized "U" shape, which is dark gray. The logo is simple and modern.
| ITEM | Predicate Device | Proposed Device | Comment |
|---|---|---|---|
| Q.freeze Software (K113408) | HYPER Focus | ||
| Product Code | KPS | KPS | same |
| Regulation Number | 21 CFR 892.1200 | 21 CFR 892.1200 | same |
| Regulatory Class | II | II | same |
| Indications for Use | MotionVUE2 (Q.freeze) is a PET/CT, no-invasive | ||
| image analysis software application designed to | |||
| support the viewing and manipulation of medical | |||
| images from PET and CT imaging modalities. | |||
| MotionVUE2 (Q.freeze) offers processing tools to | |||
| optimize workflow of respiratory gated exams for | |||
| PET. CT and fused images of respiratory gated | |||
| datasets for simultaneous viewing in multi-planar | |||
| volumes and cine loops. | |||
| MotionVUE2 (Q.freeze) allows the users to | |||
| generate from their 4D-PET or 4D-PET/CT series a | |||
| registered 4D-PET series used for quantification of | |||
| lesions and analysis of functional activity. With | |||
| MotionVUE2 (Q.freeze), users will have the | |||
| possibility to compare static PET/CT, 4D-PET/CT, | |||
| and registered 4DPET series including visual | |||
| comparison, quantification of lesions and analysis | |||
| of functional activity. | |||
| MotionVUE2 (Q.freeze) provides registration | |||
| performance of up to 2mm of center of mass motion | |||
| when motion is no larger than the diameter of the | |||
| object. | |||
| MotionVUE2 (Q.freeze) provides | |||
| comparable/equivalent improvement of | |||
| quantification results (SUV and size) as 4D PET | |||
| techniques. | |||
| MotionVUE2 (Q.freeze) can be used for features | |||
| with locally concentrated activity within the entire | HYPER Focus can be used to | ||
| correct respiratory motion in PET | |||
| images. Relative to non-corrected | |||
| images, HYPER Focus can reduce | |||
| respiratory motion effects and | |||
| thus improve the measurement | |||
| accuracy of SUV and lesion | |||
| volume. | HYPER Focus is equivalent | ||
| to the function of respiratory | |||
| motion correction of | |||
| Q.freeze. Both devices | |||
| improve the SUV and lesion | |||
| volume. | |||
| Thorax area. This area includes the organs where | |||
| PET/CT imaging has the most challenges due to | |||
| respiratory motion: Lung, Liver, Pancreas. | |||
| Algorithm | GE Healthcare Q.freeze software is designed to | ||
| minimize the effect of respiratory motion using a | |||
| non-rigid optical flow registration technique to | |||
| create a single static image containing 100% of | |||
| acquired counts. | HYPER Focus is a respiratory | ||
| motion correction technique based | |||
| on the non-rigid image | |||
| registration, which is capable of | |||
| correcting motion effects, | |||
| eliminating the activity- | |||
| attenuation mismatch artifacts, as | |||
| well as improving the accuracy of | |||
| SUV and lesion volume. It also | |||
| utilizes 100% of the acquired data | |||
| counts. | HYPER Focus has the | ||
| equivalent technological | |||
| characteristic to the function | |||
| of respiratory motion | |||
| correction of Q.freeze. Both | |||
| devices are based on non- | |||
| rigid image registration | |||
| technique. |
6
Image /page/6/Picture/1 description: The image contains the logo for United Imaging. The text "UNITED IMAGING" is in bold, sans-serif font. To the right of the text is a stylized "U" symbol, which is dark teal in color. The logo is simple and modern.
HYPER Focus has the equivalent technological characteristic to the function of respiratory motion correction of predicate device and does not introduce any new restrictions on use. HYPER Focus is as safe and effective as the predicate.
7
Image /page/7/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" in a bold, sans-serif font, stacked on top of each other. To the right of the text is a stylized "U" shape, also in a bold font, with a vertical line running through the center, creating a negative space that resembles an "I".
8. Performance Data
Non-Clinical Testing
Image performance tests were conducted for HYPER Focus during the product development.
UNITED IMAGING HEALTHCARE claims conformance to the following standards and guidance:
Software
- NEMA PS 3.1-3.20(2011): Digital Imaging and Communications in Medicine > (DICOM)
-
IEC 62304: Medical Device Software - software life cycle process
- A Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices
- A Content of Premarket Submissions for Management of Cybersecurity in Medical Devices
Other Standards and Guidance
- ISO 14971: Medical Devices Application of risk management to medical > devices
- A Code of Federal Regulations, Title 21, Part 820 - Quality System Regulation
Software Verification and Validation
Software documentation for a Moderate Level of Concern software per FDA Guidance Document "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" is included as a part of this submission. The risk analysis was completed and risk control was implemented to mitigate identified hazards. The testing results show that all the software specifications have met the acceptance criteria. Verification and validation testing of the proposed device was found acceptable to support the claim of substantial equivalence. UNITED IMAGING HEALTHCARE conforms to the Cybersecurity requirements by implementing a process of preventing unauthorized access, modification, misuse or denial of use, or unauthorized use of information that is stored, accessed, or transferred from a medical device to an external recipient. Cybersecurity information in accordance with guidance document "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices" is included in this submission.
Performance Verification
Engineering bench testing was performed to support substantial equivalence and product performance claims. The evaluation and analysis used the identical raw datasets obtained from UIH's uMI 780 (K172143) and uMI 550 (K193241), and then respectively performed image reconstruction with/without HYPER Focus.
8
Image /page/8/Picture/1 description: The image contains the logo for United Imaging. The logo consists of the words "UNITED IMAGING" stacked on top of each other in a bold, sans-serif font. To the right of the text is a stylized "U" shape, which is formed by a thick, dark line that curves around to create the "U" shape, with a vertical white line running through the center of the "U".
Bench test shows that HYPER Focus can reduce respiratory motion effects and improve the accuracy of SUV and sphere volume in comparison with no motion correction.
9. Conclusions
HYPER Focus has the equivalent technological characteristic to the function of respiratory motion correction of predicate device and does not introduce any new restrictions on use. HYPER Focus is substantially equivalent as safe as the legally marketed predicate device.
HYPER Focus is developed under UIH's quality management system. Design verification, along with bench testing demonstrates that HYPER Focus is substantially equivalent as effective as the legally marketed predicate device.
Based on the comparison and analysis above, the proposed device has similar performance, equivalent safety and effectiveness as the predicate device. The differences between the proposed device and predicate devices do not affect the indications for use, safety and effectiveness. And no issues are raised regarding safety and effectiveness. The proposed device is determined to be Substantially Equivalent (SE) to the predicate devices.